1. Home
  2. INLF vs NSPR Comparison

INLF vs NSPR Comparison

Compare INLF & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

N/A

Current Price

$0.36

Market Cap

87.3M

Sector

Industrials

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$1.64

Market Cap

77.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLF
NSPR
Founded
2016
2005
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.3M
77.5M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
INLF
NSPR
Price
$0.36
$1.64
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
167.0K
23.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.32
EPS
N/A
N/A
Revenue
N/A
$2,310,000.00
Revenue This Year
N/A
$22.91
Revenue Next Year
N/A
$72.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$1.51
52 Week High
$2.58
$3.34

Technical Indicators

Market Signals
Indicator
INLF
NSPR
Relative Strength Index (RSI) 42.77 41.82
Support Level N/A $1.56
Resistance Level $0.45 $2.51
Average True Range (ATR) 0.05 0.09
MACD -0.00 -0.02
Stochastic Oscillator 34.40 20.00

Price Performance

Historical Comparison
INLF
NSPR

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: